Research graph
References from Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease. Local targets link to admitted publications; unresolved targets remain external evidence.
The detection of monkeypox in humans in the Western Hemisphere
10.1056/nejmoa032299 · 2004 · External reference
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo
10.1073/pnas.1005769107 · 2010 · External reference
Extended Human-to-Human Transmission during a Monkeypox Outbreak in the Democratic Republic of the Congo
10.3201/eid2206.150579 · 2016 · External reference
Emerging diseases-the monkeypox epidemic in the Democratic Republic of the Congo. Clinical microbiology and infection: the official publication of the
2016 · External reference
Discovery of forgotten variola specimens at the National Institutes of Health in the USA
10.1586/14787210.2014.979157 · 2014 · External reference
The De Novo Synthesis of Horsepox Virus: Implications for Biosecurity and Recommendations for Preventing the Reemergence of Smallpox
2017 · External reference
Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates
10.1371/journal.pone.0042353 · 2012 · External reference
Clinical development of Modified Vaccinia virus Ankara vaccines
10.1016/j.vaccine.2013.03.020 · 2013 · External reference
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults
10.1093/infdis/jir527 · 2011 · External reference
Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox)
10.1128/aac.00977-13 · 2013 · External reference
Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers
10.1128/aac.00904-12 · 2012 · External reference
Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox
10.1016/j.antiviral.2017.01.009 · 2017 · External reference
A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies
10.1006/viro.1995.1378 · 1995 · External reference
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus
10.1073/pnas.0510598103 · 2006 · External reference
Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions
10.1128/jvi.78.19.10230-10237.2004 · 2004 · External reference
Differences between extracellular and intracellular forms of poxvirus and their implications
1973 · External reference
Protection against poxviruses
10.1177/003591576906200349 · 1969 · External reference
Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge
10.1128/jvi.79.21.13454-13462.2005 · 2005 · External reference
Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246
10.1128/aac.00021-09 · 2009 · External reference
ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification
10.1128/aac.01596-08 · 2009 · External reference
Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease
10.1371/journal.pone.0131742 · 2015 · External reference
Enhanced expression of a biosimilar monoclonal antibody with a novel NS0 platform
2018 · External reference
Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein
10.1016/j.virol.2007.06.042 · 2007 · External reference
its eradication
1988 · External reference
Infectiousness of smallpox relative to disease age: estimates based on transmission network and incubation period
10.1017/s0950268806007618 · 2007 · External reference
Studies on the virus content of mouth washings in the acute phase of smallpox
1961 · External reference
Virus excretion in smallpox. 2. Excretion in the throats of household contacts
1973 · External reference
Virus excretion in smallpox. 1. Excretion in the throat, urine, and conjunctiva of patients
1973 · External reference
Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus
10.1007/bf01313742 · 1989 · External reference
Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection
2017 · External reference
Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response
10.1128/jvi.00162-12 · 2012 · External reference
Smallpox vaccine safety is dependent on T cells and not B cells
10.1093/infdis/jiq162 · 2011 · External reference
Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans
10.1172/jci38506 · 2010 · External reference
Gender effects on humoral immune responses to smallpox vaccine
10.1016/j.vaccine.2009.01.086 · 2009 · External reference
Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine
10.1016/j.vaccine.2015.08.032 · 2015 · External reference
Unresolved reference
External reference
